(Adds analyst's comments in paragraphs 10 and 13) By Sabrina Valle, Milana Vinn and Amy-Jo Crowley Nov 4 (Reuters) – AstraZeneca made an offer of about $10 billion to acquire obesity drugmaker Rhythm
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Marianna Parraga HOUSTON, Nov 4 (Reuters) - The Panama Canal expects to announce the pre-qualified…
By Greg Bensinger NAPA, California, Nov 4 (Reuters) - The US federal government will lay…
Nov 5 (Reuters) - Prudential PLC: * ACHIEVEMENT OF GROUP 2026 NEW BUSINESS PROFIT GROWTH…
* Handset revenue falls 26% to $5.14 billion, below $5.25 billion estimate * Shares drop…
VIDEO SHOWS: MINUTE'S SILENCE AHEAD OF AEK ATHENS v REAL MADRID / PRESS CONFERENCE AFTER…
By Arriana McLymore NEW YORK, Nov 4 (Reuters) - Cosmetics company Elf Beauty raised its…